StockData
Purple Biotech Ltd. logo

Purple Biotech Ltd. (PPBT) stock

PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 1/30
$1.71+0.00 (0.00%)

Close on Nov 18, 2026Market cap $1.59MP/E 0.0Yield –

Purple Biotech net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$26.39M. The highest annual figure on record is $28.00M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$26.39M–
FY2024Dec 31, 2024-$7.24M–
FY2023Dec 31, 2023-$19.88M–
FY2022Dec 31, 2022-$21.67M-217.9%
FY2021Dec 31, 2021$18.38M-34.3%
FY2020Dec 31, 2020$28.00M+378.6%
FY2019Dec 31, 2019$5.85M+12.5%
FY2018Dec 31, 2018$5.20M-57.3%
FY2017Dec 31, 2017$12.18M+0.4%
FY2016Dec 31, 2016$12.13M+188.6%
FY2015Dec 31, 2015$4.20M–

More Purple Biotech figures

See a number that looks wrong?